Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06102928
Status:
RECRUITING
Last Update Posted:
2023-10-26
First Post:
2023-10-22
Brief Title:
A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation
Sponsor:
Kunming Medical University
Organization:
Kunming Medical University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor |
Keywords:
| Name | View |
|---|---|
| non-small cell lung canceranlotinibaumolertinibcombined therapyefficacy | View |